ROCKVILLE, MD – The Biophysical Society is pleased to announce that Daniel R. Larson, PhD, of the Center for Cancer Research at the National Cancer Institute within the National Institutes of Health, will receive the 2025 Carolyn Cohen Innovation Award. Larson will be honored at the Society’s 69th Annual Meeting, being held in Los Angeles, California from February 15-19, 2025.

Larson is being recognized for his pioneering contributions to the field of gene regulation using single-cell and single-molecule biophysical methods that encompass advances in both theoretical and experimental methods which have resulted in specific advances in our understanding of transcription, splicing, and gene regulation.

“It is a pleasure to see Daniel recognized for his pioneering work in single-molecule microscopy and computational modeling to illuminate vexing questions in cell biology,” said Gabriela Popescu of the University of Buffalo. “His work is an outstanding example of the innovative and transformative advances that the Carolyn Cohen Innovation Award seeks to recognize”.

About the Award - The Carolyn Cohen Innovation Award recognizes a BPS member who advances our fundamental understanding of biological systems through the development of novel theory, models, concepts, techniques, or applications. 

###

The Biophysical Society, founded in 1958, is a professional, scientific society established to lead an innovative global community working at the interface of the physical and life sciences, across all levels of complexity, and to foster the dissemination of that knowledge. The Society promotes growth in this expanding field through its Annual Meeting, publications, and outreach activities. Its 7,000 members are located throughout the world, where they teach and conduct research in colleges, universities, laboratories, government agencies, and industry.